News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
131 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27724)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Relevium Announces First Quarter Results With Revenues of $1.15M and 13% Adjusted EBITDA Margin
Relevium is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017.
November 30, 2017
·
4 min read
Drug Development
Carrick Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of its Oral CDK7 Inhibitor: CT7001
Efficacy studies are planned to start in 2018.
November 30, 2017
·
3 min read
Genetown
Boston’s Anti-Aging Startup resTORbio Scores $40M
This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year.
November 30, 2017
·
4 min read
Orexo Publishes Prospectus and Applies for Listing of Bonds on Nasdaq Stockholm
The Company intends to list the bonds on the corporate bond list of Nasdaq Stockholm.
November 30, 2017
·
2 min read
Drug Development
NeuroVive’s Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone
The objective of NeuroVive’s NVP015 program is to develop a treatment option for patients with genetic mitochondrial diseases, such as Leigh Syndrome and MELAS, when acute cellular energy support is needed, such as during an ordinary infection.
November 30, 2017
·
6 min read
FDA
FDA Clears First Medical Device Accessory for Apple Watch
AliveCor’s KardiaBand allows users to take a 30 second EKG right on the wrist.
November 30, 2017
·
4 min read
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB
Today, the last trading day of the month, there are in total 52,326,197 shares and votes in NeuroVive Pharmaceutical AB.
November 30, 2017
·
2 min read
Business
Golden Meditech Announces FY2017/2018 Interim Results
Golden Meditech announces today its interim results for the six months ended 30 September 2017.
November 30, 2017
·
14 min read
BioMidwest
RSNA Release: Smartphone Addiction Creates Imbalance in Brain
Researchers have found an imbalance in the brain chemistry of young people addicted to smartphones and the internet, according to a study presented today at the annual meeting of the RSNA.
November 30, 2017
·
3 min read
BioMidwest
RSNA Release: Brain’s Appetite Regulator Disrupted in Obese Teens
The study at the University of Sao Paulo in Brazil included 59 obese adolescents between the ages of 11 and 18 and 61 healthy control adolescents matched for gender, age, socio-economical classification and education level.
November 30, 2017
·
3 min read
1 of 14
Next